Patents by Inventor SUSAN SHU-PING

SUSAN SHU-PING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF ENHANCING AN IMMUNE RESPONSE
    Publication number: 20120135031
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Application
    Filed: June 27, 2011
    Publication date: May 31, 2012
    Applicant: TAPIMMUNE, INC.
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti
  • METHOD FOR ENHANCING AN IMMUNE RESPONSE
    Publication number: 20110212131
    Abstract: A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 1, 2011
    Applicant: TAPIMMUNE, INC.
    Inventors: Wilfred Arthur Jefferies, Timothy Z. Vitalis, Quian-Jin Zhang, Judi Barbara Alimonti, Susan Shu-Ping Chen, Genc Basha, Kyung Bok Choi
  • Method of enhancing an immune response
    Patent number: 7994146
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Grant
    Filed: February 11, 2008
    Date of Patent: August 9, 2011
    Assignee: Tapimmune, Inc.
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti
  • treatment
    Patent number: 7976850
    Abstract: A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.
    Type: Grant
    Filed: May 29, 2009
    Date of Patent: July 12, 2011
    Assignee: Tapimmune, Inc.
    Inventors: Wilfred Arthur Jefferies, Timothy Z. Vitalis, Quian-Jin Zhang, Judi Barbara Alimonti, Susan Shu-Ping Chen, Genc Basha, Kyung Bok Choi
  • LOW DOSE INOCULATION WITH TAP FOR ANTI-TUMOR IMMUNITY
    Publication number: 20100322963
    Abstract: A safe and efficacious method of inducing protective immunity in animals against TAP-1 deficient metastatic melanoma is disclosed. The method involves treating the animals with relatively small amounts of a recombinant non-replicating adenovirus encoding human TAP-1 to promote and maintain long term anti-tumor survival, and enhanced memory T-cell subpopulations, even when the treatment effects only a small fraction of metastatic tumor cells.
    Type: Application
    Filed: June 18, 2009
    Publication date: December 23, 2010
    Applicant: Tapimmune, Inc.
    Inventors: WILFRED A. JEFFERIES, YUANMEI LOU, ROBYN P. SEIPP, SUSAN SHU-PING, TIMOTHY Z. VITALIS, TERRY W. PEARSON
  • POX VIRIDAE TREATMENT
    Publication number: 20100303894
    Abstract: A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 2, 2010
    Applicant: University of British Columbia
    Inventors: Wilfred Arthur Jefferies, Timothy Z. Vitalis, Quian-Jin Zhang, Judi Barbara Alimonti, Susan Shu-Ping Chen, Genc Basha, Kyung Bok Choi
  • METHOD OF ENHANCING AN IMMUNE RESPONSE
    Publication number: 20100080776
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Application
    Filed: February 11, 2008
    Publication date: April 1, 2010
    Applicant: Taplmmune, Inc.
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti
  • Method of enhancing an immune response
    Patent number: 7378087
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: May 27, 2008
    Assignee: TapImmune, Inc.
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti
  • Method of enhancing an immune response
    Publication number: 20030082195
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Application
    Filed: January 16, 2002
    Publication date: May 1, 2003
    Applicant: The University of British Columbia
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti